Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) Consolidated Diluted EPS At -0.3995

0

For the year ended 2015-06-30 Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) basic consolidated EPS came $-0.3995. Furthermore, for the quarter closed 2015-06-30, it was $-0.3995.

Consolidated diluted EPS

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) consolidated diluted EPS was -0.3995 for the year ended 2015-06-30. For the quarter ended 2015-06-30, it stood at $-0.3995.

EPS contribution from parent

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) basic EPS was $-0.3995 for the year ended 2015-06-30 from its parent entity. It was $-0.3995 for the quarter closed 2015-06-30.

EPS from continuing operations

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) EPS from continuing activities was $-0.3995 for the fiscal ended 2015-06-30. For the quarter ended 2015-06-30, this figure was $-0.3995.

Basic net EPS

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) basic net EPS was $-0.3783 for the year ended 2015-06-30. For the quarter ended 2015-06-30, it came at $-0.3783.

Diluted EPS from parent

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) diluted EPS from parent entity came at $-0.3995 for the year ended 2015-06-30. For the quarter ended 2015-06-30 it was $-0.3995.

Net diluted EPS

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) net diluted EPS was $-0.3783 for the fiscal closed 2015-06-30. For the quarter ended 2015-06-30, net diluted EPS was $-0.3783.

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) net basic EPS was $-0.42 for the year ended 2015-06-30. For the quarter ended 2015-06-30, it was $-0.42.

Basic diluted EPS

Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) basic diluted EPS was $-0.22 for the quarter ended 2015-06-30. For the year ended 2015-06-30, basic diluted EPS was $-0.22.

For the year ended 2015-06-30, basic shares outstanding were 54.169 while for the quarter ended 2015-06-30 is 54.169.

For the fiscal ended 2015-06-30, the diluted outstanding shares were 54.169 and for the quarter ended 2015-06-30 it was 54.169. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 43 times, 1 visits today)